Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Protagonist Therapeutics (PTGX) Receivables - Net (2017 - 2021)

Protagonist Therapeutics (PTGX) has disclosed Receivables - Net for 5 consecutive years, with $100000.0 as the latest value for Q1 2021.

  • Quarterly Receivables - Net fell 66.67% to $100000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $100000.0 through Mar 2021, down 66.67% year-over-year, with the annual reading at $300000.0 for FY2019, 2.91% down from the prior year.
  • Receivables - Net hit $100000.0 in Q1 2021 for Protagonist Therapeutics, roughly flat from $100000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $700000.0 in Q3 2019 to a low of $19000.0 in Q2 2017.
  • Historically, Receivables - Net has averaged $199266.7 across 5 years, with a median of $103000.0 in 2017.
  • Biggest five-year swings in Receivables - Net: surged 459.38% in 2019 and later crashed 72.07% in 2020.
  • Year by year, Receivables - Net stood at $58000.0 in 2017, then soared by 432.76% to $309000.0 in 2018, then decreased by 2.91% to $300000.0 in 2019, then plummeted by 66.67% to $100000.0 in 2020, then changed by 0.0% to $100000.0 in 2021.
  • Business Quant data shows Receivables - Net for PTGX at $100000.0 in Q1 2021, $100000.0 in Q2 2020, and $300000.0 in Q1 2020.